UK Promises ‘Competitive’ Clinical Trial Process Whatever The Brexit Outcome

The UK pharmaceutical industry has welcomed government guidance on the clinical trial regulatory landscape after Brexit, as well as a report from Cancer Research UK on the need to preserve alignment with the EU’s Clinical Trial Regulation.

Clinical trials — The UK is promising a "competitive" post-Brexit clinical environment

The UK says it plans to keep its clinical trial regulations aligned with those of the EU during any Brexit transition period, and that even if the UK leaves without a deal it will put in place a “competitive” service for clinical trials with a “streamlined” parallel assessment service that delivers approvals within the same timeframes as the EU.

The pledge is made in a guidance document published by the government on what will happen in the life...